For the year ending 2025-12-31, CTM had $2,629,730 increase in cash & cash equivalents over the period. -$2,100,118 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -2,398,292 |
| Depreciation and amortization | 1,498,864 |
| Amortization of discounts, premiums and deferred cost | 0 |
| Share-based compensation | 2,475,687 |
| Deferred tax provision | 0 |
| Gain on lease termination | 0 |
| Gain on sale of reporting unit | 0 |
| Goodwill impairment loss | 0 |
| Lease cost | 275,913 |
| Change in fair value of contingent earnout | 0 |
| Change in fair value of derivative liabilities | 621,000 |
| Gain from timing difference on issuance of shares | 0 |
| Accounts receivable | 2,620,686 |
| Proceeds from factoring accounts receivable | 0 |
| Prepaid expenses and other current assets | 118,594 |
| Contract asset and liabilities | 298,558 |
| Lease liabilities | -270,049 |
| Accounts payable and accrued expenses | 128,338 |
| Net cash (used in) provided by operating activities | -1,948,377 |
| Acquisition of business, cash paid to seller | 0 |
| Sale of subsidiary, cash received from buyer | 92,218 |
| Cash from factoring | 0 |
| Investment in joint ventures | 100,250 |
| Acquisition of business, cash received from seller | 0 |
| Investment in captive insurance entity | 0 |
| Purchases of fixed assets | 151,741 |
| Net cash (used in) provided by investing activities | -159,773 |
| Proceeds from revolving credit line | 0 |
| Repayment of line of credit, net | 1,999,944 |
| Settlement of stock compensation in cash | -128,207 |
| Payment of debt issuance costs | 12,844 |
| Proceeds from issuance of preferred and common stock, and regular warrants, net of issuance costs | 15,299,817 |
| Proceeds from note payable | 0 |
| Proceeds from exercise of stock options | 26,500 |
| Preferred stock dividend | 107,442 |
| Loss on induced conversion | 0 |
| Repayment of convertible note payable related party | 0 |
| Repayment of amounts due to seller | 340,000 |
| Repayment of notes payable | 8,000,000 |
| Net cash (used in) provided by financing activities | 4,737,880 |
| Net increase (decrease) in cash | 2,629,730 |
| Cash and restricted cash - beginning of period | 12,255,048 |
| Cash and restricted cash - end of period | 14,884,778 |
Castellum, Inc. (CTM)
Castellum, Inc. (CTM)